Sat.Jan 06, 2024 - Fri.Jan 12, 2024

article thumbnail

Wholesalers Aim to Support Pharmacy Partners Amid Shifting Pharmacy Landscape

Pharmacy Times

Claire Biermaas, President of Corporate Partnerships at Cencora, discussed how her team is working with their partners to address new challenges amid the shifting landscape of pharmacy.

139
139
article thumbnail

Pfizer COVID-19 Vaccine Significantly Protected Children, Adolescents During Pandemic

Drug Topics

The estimated efficacy of the vaccine against documented infection for children and adolescents during the Omicron wave was 74.3% and 85.5%, respectively.

Vaccines 219
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

As she drives research on structural racism in health care, Rachel Hardeman faces a painful reckoning

STAT

MINNEAPOLIS — It’s been almost four years since George Floyd was murdered here at 38th Street and Chicago Avenue, a South Minneapolis corner anchored by a convenience store, its red awning still achingly familiar from once-saturating news coverage. Now, the legions of teddy bears placed in Floyd’s honor are dusty, the paint on street murals has chipped away, and community-built planters are overgrown.

145
145
article thumbnail

UnitedHealth Group kicks off payer earnings, reports $5.5B in Q4 profit

Fierce Healthcare

Industry giant UnitedHealth Group kicked off fourth-quarter earnings for major payers on Friday morning, where it reported $5.5 billion in profit. | Industry giant UnitedHealth Group kicked off fourth-quarter earnings for major payers on Friday morning, where it reported $5.5 billion in profit.

143
143
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

FDA Approves BrainSee, First-in-Class Test to Predict Progression of Alzheimer Disease

Pharmacy Times

BrainSee creates a new standard for progression prediction in Alzheimer disease, marking a step forward in brain health management with non-invasive screening.

FDA 178
article thumbnail

Advocacy Key For Supporting Transgender Rights in Health Care Settings

Drug Topics

Advocates can amplify the voices of transgender patients as they overcome barriers to health care, said Molly Crowther in a conversation at the 2023 Healthcare Advocate Summit.

198
198

More Trending

article thumbnail

JPM24: Amazon rolls out service to connect customers with digital health benefits, taps Omada Health as launch partner

Fierce Healthcare

SAN FRANCISCO—Amazon plans to collaborate with digital health companies to connect customers with virtual care benefits for managing conditions like diabetes and hypertension. | Amazon plans to collaborate with digital health companies to connect customers with virtual care benefits for managing conditions like diabetes and hypertension. The online retail giant tapped virtual-first chronic care provider Omada Health as its first partner.

141
141
article thumbnail

Here’s to Our Local Heroes: America’s Pharmacists

Pharmacy Times

We owe it to our seniors to listen to their needs and ensure pharmacists have the support they need to continue to play a vital role in our communities as frontline providers of essential health care.

149
149
article thumbnail

Loneliness Associated With Greater Burden of Care Among Caregivers of Children With Type 1 Diabetes

Drug Topics

These findings can help health care professionals develop a family-centered treatment plan for pediatric type 1 diabetes, considered a “family disease” by study authors.

185
185
article thumbnail

STAT+: Contributors to psychiatry’s bible, the DSM-5, got $14 million from industry

STAT

Amid ongoing concerns over conflicts of interest, a new study found that 60% of the physicians who served as panel and task force members for the American Psychiatric Association’s official manual of psychiatric disorders received payments from industry totaling more than $14 million. And the authors argue the findings raise questions about the editorial independence of the reference book.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

JPM24: Pfizer CEO promises 'year of execution' after recent struggles, Seagen buyout

Fierce Pharma

Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. | Pfizer knows it had a bad year in 2023. Speaking to reporters at the 2024 J.P. Morgan Healthcare Conference on Monday, the company’s CEO, Albert Bourla, spoke bluntly about the hits the company took, and he acknowledged the underperformance of certain key launches.

137
137
article thumbnail

Purchasing Discounted Medications Online Can Pose Dangers for Patients

Pharmacy Times

With the increase in counterfeit GLP-1 and GLP/GIP medications available online, education may be needed for patients around the dangers of unregulated medications.

149
149
article thumbnail

Reduced Drug Use Could Help Patients With Stimulant Use Disorders Achieve Recovery

Drug Topics

A recent study found that reduced drug use was associated with a decrease in cravings, drug seeking behaviors, and depression severity.

191
191
article thumbnail

Patients’ social needs often get lost in health records. Generative AI could help

STAT

Generative AI’s earliest applications in medicine have largely focused on curing not patients, but the plague of productivity physicians lose to digital documentation. Now, research suggests a way that large language models like ChatGPT could benefit both patients and providers: by automatically extracting a patient’s social needs from reams of text in their clinical records.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

CES 2024: Older seniors are happily living with AI—in the form of chatty robot ElliQ

Fierce Healthcare

LAS VEGAS — With all the buzz and headlines about artificial intelligence, there is one demographic that is quietly embracing the technology and even building long-term relationships with it. | With all the buzz and headlines about artificial intelligence, there is one demographic that is quietly embracing the technology and even building long-term relationships with it.

137
137
article thumbnail

Real-World Experience With Continuous Glucose Monitoring Is an “Eye-Opening” Experience

Pharmacy Times

Most important of all, we gained a new level of empathy and understanding for patients diagnosed with diabetes whose diagnosis requires that they are constantly mindful and attentive to the balance of diet, exercise, and lifestyle in their day-to-day lives.

144
144
article thumbnail

JPM: Four ways FDA is seeking to buoy gene therapy

pharmaphorum

Dr Peter Marks, director of the FDA Center for Biologics Evaluation and Research told a packed house in San Francisco for JPM that FDA wants to support gene therapies in 2024.

FDA 138
article thumbnail

Opinion: Addressing the Black youth suicide crisis requires a new approach to licensing clinical social workers

STAT

In the spring of 2020, Jamal Clay , a gifted young man who grew up in the south suburbs of Chicago, died by suicide. He was 19 years old. Jamal’s loved ones describe him as creative and talented, a leader in different youth-focused organizations in his community who supported and cared for those he loved. He was just as brilliant as he was kind.

144
144
article thumbnail

JPM24: Top trends for payers, providers and health tech companies to watch

Fierce Healthcare

We've closed the books on another hectic J. | We covered some of the biggest headlines from the four-day conference and after parsing through all the presentations, interviews and panel discussions, we tracked a handful of key trends dominating the conversations.

135
135
article thumbnail

Pharmacy Focus: A Glimpse into Independent Prescribing

Pharmacy Times

Tune in to this episode of Pharmacy Focus for a deep dive into the world of independent pharmacists prescribing, featuring insights and expertise from Deeb Eid.

153
153
article thumbnail

JPM24: As cancer players jump head-first into ADC field, Novartis CEO explains how he's resisted the temptation

Fierce Pharma

San Francisco—Nearly all top cancer drugmakers have struck deals in the sizzling antibody-drug conjugate field—but not Novartis. | Nearly all top cancer drugmakers have struck deals in the sizzling antibody-drug conjugate field—but not Novartis. On Monday, the Swiss pharma’s CEO Vas Narasimhan explained how he's resisted the temptation.

130
130
article thumbnail

Opinion: Americans are obsessed with health and fitness tracking. It’s time for a data diet

STAT

Turn on your TV or open a web browser this January, and you’ll be bombarded with ads for fitness trackers, smart scales, health apps, and other digital innovations promising to streamline your journey to a happier and healthier you. It’s the time of year when we’re most susceptible to such messaging: Surveys show that at least one-third of our New Year’s resolutions focus on exercising, losing weight, or eating better.

144
144
article thumbnail

CES 2024: Elevance Health launches program to provide digital health-enabled smartphones to Medicaid members

Fierce Healthcare

In the wake of the COVID-19 pandemic, virtual care and digital health tools are more popular than ever. | Elevance Health is launching a new initiative that aims to put smartphones in the hands of Medicaid members who otherwise cannot connect to virtual services.

136
136
article thumbnail

Patients With Gestational Diabetes May Have 2 Categories of Genetic Risk Factors

Pharmacy Times

These patients may have a similar genetic susceptibility for type 2 diabetes, although they have an individual risk for GDM independent of the risk of type 2 diabetes.

145
145
article thumbnail

How Quantum Computing Will Impact Pharma in 2024: Q&A With Erik Huestis, Partner at Foley Hoag

PharmExec

Huestis discusses the ways that quantum simulation and quantum systems can be used in areas such as drug discovery and the creation and protection of intellectual property in the life sciences industry.

126
126
article thumbnail

STAT+: Insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM

STAT

New artificial intelligence technologies made headlines last year for their ability to do everything from generating fake musical duets to understanding how proteins fold. But in biotech, one of the most well-funded AI players has been quiet. Insitro, a South San Francisco firm, was founded in 2018 by Daphne Koller, who had previously been a Stanford professor, a 2004 MacArthur “genius” grant recipient, and the co-founder and co-CEO of the online course company Coursera.

145
145
article thumbnail

Hims & Hers grows health system partnerships, taps Hartford HealthCare for in-person primary care

Fierce Healthcare

SAN FRANCISCO — Virtual care company Hims & Hers is collaborating with Hartford HealthCare to connect patients in Connecticut with in-person primary and specialty care services. | Virtual care company Hims & Hers is collaborating with Hartford HealthCare to connect patients in Connecticut with in-person primary and specialty care services.

130
130
article thumbnail

FDA Approves Berdazimer Topical Gel as First Treatment for Molluscum Contagiosum

Pharmacy Times

Berdazimer topical gel, 10.3% (Zelsuvmi; Ligand Pharmaceuticals Inc) has been approved for the treatment of molluscum contagiosum in individuals aged 1 year and older.

FDA 145
article thumbnail

JPM24: Merck expects $20B+ in post-Keytruda cancer sales thanks to Daiichi ADC deal, Moderna vaccine

Fierce Pharma

While some Merck & Co. investors may still get the heebie-jeebies when thinking about Keytruda’s patent cliff in 2028, but the company’s CEO Rob Davis now thinks “it’s just another year.” | While some Merck & Co. investors may still get the heebie-jeebies when thinking about Keytruda’s patent cliff in 2028, but the company’s CEO Rob Davis now thinks “it’s just another year.

Vaccines 120
article thumbnail

STAT+: Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution

STAT

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that the U.S. was wasting the grand potential of CRISPR gene editing. Fyodor Urnov, the scientist in question, estimates he gave the talk 30 to 40 times: to fellow researchers, pharma executives, Food and Drug Administration officials, congressional staff, journalists, patient advocates.

144
144
article thumbnail

JPM24: Cigna's top brass says PBM Express Scripts is poised to weather industry reform

Fierce Healthcare

Last August, Blue Shield of California made headlines when it rev | As the market shifts toward greater transparency, Express Scripts has rolled out multiple programs in the past year that aim to address some of the central criticisms of the industry.

128
128
article thumbnail

Behind the Counter: Unveiling the Multifaceted Role of Pharmacists

Pharmacy Times

Pharmacists in community and retail practices are stepping out from behind the counter and becoming more involved in patient care.

article thumbnail

Data-driven disease research harnessing the genome

pharmaphorum

Discover how the UK Biobank is leveraging technology and the power of genomics in data-driven disease research. Join the digital revolution in understanding and combating diseases using cutting-edge techniques and large-scale genomic data analysis.

125
125
article thumbnail

The Afghan father aided U.S. soldiers. Now Texas Medicaid won’t pay for his son’s gene therapy

STAT

On a sweltering day in August 2021, as the engines of a hulking C-17 cargo plane drowned out pops of gunfire and Taliban rocket explosions around them, the young Afghan couple looked down at their 4-month-old son, Mohammad, and felt a shuddering wave of relief. But as the plane lifted above the dusty peaks that hug Kabul like a fortress of sandstone and schist, that feeling grew heavy with grief — for the parents and siblings they were leaving behind, and for Afghanistan, the only home th

FDA 144